Dabur Research Foundation (DRF) is an Indian Contract Research Organization Est.1979 offering preclinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies. We offer preclinical services to global Biotech, Pharma, Phytopharmaceuticals Cosmeceuticals and academia sectors. Our services broadly fall into the functional areas of In Vitro, Ex-Vivo & In Vivo Pharmacology, Exploratory & GLP Toxicology & DMPK. Our genesis is from the Dabur group of companies; we started operating as a preclinical service provider after a strategy spin-off from our parent company in the year 2008. It is this experience of 30 years of drug discovery & development that we bring to our clients as a preclinical service provider.
Established by a team of accomplished entrepreneurs & drug discovery scientists. Extensive knowledge and experience in translational research of Synthetic & botanical leads.
Offering innovative preclinical & product development solutions to our partners for phytopharmaceutical & pharmaceutical products.
20+ years of comprehensive services for Health & Wellness, Pharma, Biotech, Nutraceutical & Agrochemical to facilitate global registration requirements.
OECD GLP & AAALAC compliant.
100+ scientists recruited from the top 5 Universities of India; PhD : Master’s 1:2.
100+ years of cumulative management experience in preclinical research.
Institution Biosafety Committee, Institution Animal Ethics Committee & Occupational Health & Safety Committee ensure effective operation.